Skip to main content
OpenTrials
Completed

NCT Number: NCT04364412

Acute Lower gastroIntestinal BleedIng (ALIBI Study) in Italy

Unlike upper GI bleeding, for LGIB there is still a paucity of data on clinical presentation, patient characteristics, pathways of care and outcomes for LGIB patients. In-hospital mortality ranges from 1.2% to 8.8% (2-4), according to retrospective studies, but data from prospective series are still limited (5).

Present multicentre, prospective, observational study was designed to explore these areas, to assess variations in practice management and to identify factors associated with patient outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lower GI Bleeding

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Valduce Hospital

Como, 22100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult patients with acute lower GI bleeding

Exclusion criteria

  • age below 18 years
  • bleeding patients with an upper GI source

Treatment and study plan

Primary outcomes

  1. Mortality rate in patients admitted for acute lower GI bleeding

    Time frame: 4 weeks

    Number of deaths among the study cohort

Sponsors and collaborators

Lead sponsor

Valduce Hospital

Other

Registry information

Official study title

Acute Lower gastroIntestinal BleedIng (ALIBI Study): a Multicentre Prospective, Cohort Study

Acronym: ALIBI

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Apr 28, 2020
Registry last updated
May 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.